Apremilast Therapy for Acute Gouty Arthritis.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2018
At a glance
- Drugs Apremilast (Primary) ; Indometacin
- Indications Gout
- Focus Therapeutic Use
- 05 Jul 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 27 Oct 2009 New trial record